Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid-Adrenaline-Bupivacaine Hydrogel vs Silver-Containing Foam Dressing for Split-Thickness Skin Graft Donor Sites
TCTR20250417004Phase 2Recruiting
- Sponsor
- Nakornping Hospital
- Start
- Apr 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of tranexamic acid, epinephrine, bupivacaine in split-thickness skin graft donor site wound, sponsored by Nakornping Hospital. Started Apr 2025; status: recruiting.
02
Drugs
tranexamic acidepinephrinebupivacaine
03
Conditions
split-thickness skin graft donor site wound
Beyond the preview
Go deeper on TCTR20250417004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250417004.